IGHG3 and Alzheimer disease: To this end, primary mouse neurons were treated for 24 h with aCSF, non-AD control extracts (n=3) or extracts from AD patients (n=7) that were either untreated or immunodepleted with ALZ-201, 4G8 or IgG3.